サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1260074

エルシニア診断薬市場- 成長、将来展望、競合分析、2023年～2031年

Yersinia Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日: | 発行: Acute Market Reports | ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
エルシニア診断薬市場- 成長、将来展望、競合分析、2023年～2031年
出版日: 2023年01月10日
発行: Acute Market Reports
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Yersiniaは、末端回腸炎、腸炎、急性下痢、腸間膜リンパ節炎、敗血症などを引き起こすグラム陽性菌です。エルシニア菌は、胃腸炎やペストの原因となる菌で、小児に多く、女性よりも男性に多くみられます。さらに、ペストやエルシニア症の有病率は北米、北欧、スカンジナビアで高いと言われており、これらの地域はエルシニア診断薬の最大市場となっています。さらに、新しい分子診断ツールの導入が進み、認知度が高まっていることも、これらの市場の優位性に寄与しています。一方、アジア太平洋地域のエルシニア診断薬市場は、アジアの新興国に未開拓の機会が広く存在し、日本ではエルシニア感染症の有病率が非常に高いことから、大きな可能性を秘めています。

エルシニア感染症の治療には、アミノグリコシド系、セファロスポリン系、テトラサイクリン系、トリメトプリム-スルファメトキサゾール（TMP-SMZ）、フルオロキノロン系などの薬剤が用いられます。診断方法としては、ELISA法、チューブ凝集法、ラジオイムノアッセイ法、超音波法、便培養法、CTスキャン法、大腸内視鏡法などが用いられます。また、エルシニア・エンテロコリチカ分離株の確定検出は、16S rRNA遺伝子の塩基配列決定によって行うことができます。また、プラスモジアルにコードされたエルシニアタンパクを用いたイムノブロットにより、血清学的な同定も可能です。しかし、直接的・間接的な診断に適用できる、より高感度で効率的、かつ簡便な迅速診断システムの開発は、この市場における課題として残っています。

本レポートで回答した主な質問

エルシニア診断薬市場の成長に影響を与える主要なミクロおよびマクロ環境要因は何か？

現在および予測期間中の製品セグメントおよび地域に関する主要な投資ポケットは何か？

2031年までの推定推計・市場予測

予測期間中に最も速いCAGRを占めるのはどのセグメントか？

より大きな市場シェアを持つ市場セグメントとその理由は？

低・中所得国はエルシニア診断薬市場に投資しているか？

エルシニア診断薬市場の地域別市場規模が最も大きいのはどこか？

アジア太平洋、ラテンアメリカ、中東・アフリカなどの新興市場における市場動向と力学は？

エルシニア診断薬市場の成長を促進する主要動向は何か？

世界のエルシニア診断薬市場で存在感を高めるための主要な競合企業とその主要戦略は何か？

目次

第1章 序文

  • レポート内容
    • 報告書の目的
    • 対象読者
    • 主な提供商品
  • 市場セグメンテーション
  • 調査手法
    • フェーズⅠ-二次調査
    • フェーズⅡ-一次調査
    • フェーズⅢ-有識者別レビュー
    • 前提条件
    • 採用したアプローチ

第2章 エグゼクティブサマリー

  • 市場のスナップショット：世界のエルシニア診断薬市場
  • 世界のエルシニア診断薬市場：テスト別 2022
  • 世界のエルシニア診断薬市場：技術別 2022
  • 世界のエルシニア診断薬市場：地域別 2022
  • 魅力的な投資提案：地域別 2022

第3章 エルシニア診断薬市場：競合分析

  • 主要ベンダーの市場ポジショニング
  • ベンダーが採用する戦略
  • 主要な産業戦略
  • ティア分析：2022 vs 2031

第4章 エルシニア診断薬市場：マクロ分析と市場力学

  • イントロダクション
  • 世界のエルシニア診断薬市場金額 2021-2031
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析

第5章 エルシニア診断薬市場：テスト別 2021-2031

  • 市場概要
  • 成長・収益分析：2022 vs 2031
  • 市場セグメンテーション
    • 糞便培養
    • ELISA
    • ラジオイムノアッセイ
    • チューブ凝集
    • CTスキャン
    • 超音波検査
    • 大腸内視鏡検査

第6章 エルシニア診断薬市場：技術別 2021-2031

  • 市場概要
  • 成長・収益分析：2022 vs 2031
  • 市場セグメンテーション
    • DNAプローブ
    • イムノアッセイ
    • モノクローナル抗体
    • PCR
    • その他

第7章 北米のエルシニア診断薬市場 2021-2031

  • 市場概要
  • エルシニア診断薬市場：テスト別 2021-2031
  • エルシニア診断薬市場：技術別 2021-2031
  • エルシニア診断薬市場：地域別 2021-2031
    • 北米
      • 米国
      • カナダ
      • その他北米地域

第8章 英国と欧州連合のエルシニア診断薬市場 2021-2031

  • 市場概要
  • エルシニア診断薬市場：テスト別 2021-2031
  • エルシニア診断薬市場：技術別 2021-2031
  • エルシニア診断薬市場：地域別 2021-2031
    • 英国と欧州連合
      • 英国
      • ドイツ
      • スペイン
      • イタリア
      • フランス
      • その他欧州地域

第9章 アジア太平洋のエルシニア診断薬市場 2021-2031

  • 市場概要
  • エルシニア診断薬市場：テスト別 2021-2031
  • エルシニア診断薬市場：技術別 2021-2031
  • エルシニア診断薬市場：地域別 2021-2031
    • アジア太平洋
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域

第10章 ラテンアメリカのエルシニア診断薬市場 2021-2031

  • 市場概要
  • エルシニア診断薬市場：テスト別 2021-2031
  • エルシニア診断薬市場：技術別 2021-2031
  • エルシニア診断薬市場：地域別 2021-2031
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • その他ラテンアメリカ地域

第11章 中東・アフリカのエルシニア診断薬市場 2021-2031

  • 市場概要
  • エルシニア診断薬市場：テスト別 2021-2031
  • エルシニア診断薬市場：技術別 2021-2031
  • エルシニア診断薬市場：地域別 2021-2031
    • 中東・アフリカ
      • GCC
      • アフリカ
      • その他中東・アフリカ地域

第12章 企業プロファイル

  • Abbott Laboratories Inc.
  • Affymetrix Inc.
  • Becton Dickinson
  • Bio-Rad Laboratories
  • Danaher Corporation
  • F. Hoffmann La-Roche
  • Gen-probe
  • Hologic
  • Thermo Fisher Scientific
  • その他の注目選手
図表

List of Tables

  • TABLE 1 Global Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 2 Global Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 3 North America Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 4 North America Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 5 U.S. Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 6 U.S. Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 7 Canada Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 8 Canada Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 9 Rest of North America Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 10 Rest of North America Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 11 UK and European Union Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 12 UK and European Union Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 13 UK Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 14 UK Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 15 Germany Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 16 Germany Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 17 Spain Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 18 Spain Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 19 Italy Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 20 Italy Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 21 France Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 22 France Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 23 Rest of Europe Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 24 Rest of Europe Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 25 Asia Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 26 Asia Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 27 China Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 28 China Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 29 Japan Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 30 Japan Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 31 India Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 32 India Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 33 Australia Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 34 Australia Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 35 South Korea Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 36 South Korea Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 37 Latin America Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 38 Latin America Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 39 Brazil Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 40 Brazil Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 41 Mexico Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 42 Mexico Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 43 Rest of Latin America Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 44 Rest of Latin America Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 45 Middle East and Africa Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 46 Middle East and Africa Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 47 GCC Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 48 GCC Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 49 Africa Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 50 Africa Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Yersinia Diagnostics Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Yersinia Diagnostics Market: Quality Assurance
  • FIG. 5 Global Yersinia Diagnostics Market, By Test, 2022
  • FIG. 6 Global Yersinia Diagnostics Market, By Technology, 2022
  • FIG. 7 Global Yersinia Diagnostics Market, By Geography, 2022
  • FIG. 8 Market Geographical Opportunity Matrix - Global Yersinia Diagnostics Market, 2022
  • FIG. 9 Market Positioning of Key Yersinia Diagnostics Market Players, 2022
  • FIG. 10 Global Yersinia Diagnostics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 11 Global Yersinia Diagnostics Market, By Test, 2022 Vs 2031, %
  • FIG. 12 Global Yersinia Diagnostics Market, By Technology, 2022 Vs 2031, %
  • FIG. 13 U.S. Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 14 Canada Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 15 Rest of North America Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 16 UK Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 17 Germany Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 18 Spain Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 19 Italy Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 20 France Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 21 Rest of Europe Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 22 China Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 23 Japan Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 24 India Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 25 Australia Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 26 South Korea Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 27 Rest of Asia Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 28 Brazil Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 29 Mexico Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 30 Rest of Latin America Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 31 GCC Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 32 Africa Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 33 Rest of Middle East and Africa Yersinia Diagnostics Market (US$ Million), 2021 - 2031
目次
Product Code: 137967-01-23

Yersinia is a gram-positive bacteria causing terminal ileitis, enterocolitis, acute diarrhea, mesenteric lymphadenitis, and sepsis. Species of Yersinia cause gastroenteritis and bubonic plague and are often observed in children, and men more than women. Moreover, the prevalence of bubonic plague and yersiniosis is reportedly high in North America, North Europe, and Scandinavian counties, making these regions the largest markets for Yersinia diagnostics. Furthermore, greater adoption of novel molecular diagnostic tools and higher awareness also contribute to the dominance of these markets. On the other hand, the Asia Pacific Yersinia diagnostics market holds great potential due to the wide presence of untapped opportunities in emerging Asian countries and the significantly high prevalence of Yersinia infection in Japan.

Treatment of Yersinia infections includes drugs such as aminoglycosides, cephalosporins, tetracyclines, trimethoprim-sulfamethoxazole (TMP-SMZ), and fluoroquinolones. The diagnostic methods used include ELISA, tube agglutination, radioimmunoassay, ultrasonography, stool culture, CT scan, and colonoscopy. Definite detection of Yersinia enterocolitica isolates can also be performed through sequencing of the 16S rRNA gene. Immunoblot with plasmodial encoded Yersinia protein also enables serological identification. However, developing more sensitive, efficient, and yet simple rapid diagnostic systems that can be applied to direct and indirect diagnosis remains a challenge in this market.

Key players identified for the Yersinia Diagnostics market include but are not limited to:

Abbott Laboratories, Inc., Affymetrix, Inc., Becton Dickinson, Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann La-Roche, Gen-probe, Hologic, Thermo Fisher Scientific, and Other notable players.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Yersinia Diagnostics market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Yersinia Diagnostics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Test

Stool Culture

ELISA

Radioimmunoassay

Tube Agglutination

CT Scan

Ultrasonography

Colonoscopy

Technology

DNA Probes

Immunoassay

Monoclonal Antibodies

PCR

Others

Region Segment (2021-2031; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Yersinia Diagnostics market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Yersinia Diagnostics market?

Which is the largest regional market for Yersinia Diagnostics market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Yersinia Diagnostics market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Yersinia Diagnostics market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Yersinia Diagnostics Market
  • 2.2. Global Yersinia Diagnostics Market, By Test, 2022 (US$ Million)
  • 2.3. Global Yersinia Diagnostics Market, By Technology, 2022 (US$ Million)
  • 2.4. Global Yersinia Diagnostics Market, By Geography, 2022 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2022

3. Yersinia Diagnostics Market: Competitive Analysis

  • 3.1. Market Positioning of Key Yersinia Diagnostics Market Vendors
  • 3.2. Strategies Adopted by Yersinia Diagnostics Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Yersinia Diagnostics Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Yersinia Diagnostics Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Stool Culture
    • 5.3.2. ELISA
    • 5.3.3. Radioimmunoassay
    • 5.3.4. Tube Agglutination
    • 5.3.5. CT Scan
    • 5.3.6. Ultrasonography
    • 5.3.7. Colonoscopy

6. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. DNA Probes
    • 6.3.2. Immunoassay
    • 6.3.3. Monoclonal Antibodies
    • 6.3.4. PCR
    • 6.3.5. Others

7. North America Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 7.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 7.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 7.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 7.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 7.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

8. UK and European Union Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 8.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 8.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.4.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.5.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.6.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

9. Asia Pacific Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 9.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 9.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.4.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.5.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.6.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

10. Latin America Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 10.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 10.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 10.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 10.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 10.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

11. Middle East and Africa Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 11.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 11.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 11.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 11.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 11.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

12. Company Profile

  • 12.1. Abbott Laboratories, Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Affymetrix, Inc.
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Becton Dickinson
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Bio-Rad Laboratories
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Danaher Corporation
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. F. Hoffmann La-Roche
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Gen-probe
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Hologic
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Thermo Fisher Scientific
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Other notable players
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives